Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients.
Kim H, Kang HJ, Park KD, Koh KN, Im HJ, Seo JJ, Lee JW, Chung NG, Cho B, Kim HK, Lee JM, Hah JO, Lee JA, Lee YH, Park SK, Baek HJ, Kook H, Kim JY, Kim HS, Kim HM, Chueh HW, Park M, Yoon HS, Lee MJ, Choi HS, Ahn HS, Kawano Y, Park JW, Hahn S, Shin HY.
Kim H, et al. Among authors: hah jo.
Cancer Res Treat. 2019 Jan;51(1):357-367. doi: 10.4143/crt.2017.457. Epub 2018 May 14.
Cancer Res Treat. 2019.
PMID: 29764117
Free PMC article.